Status:

ENROLLING_BY_INVITATION

HIV-Mental Illness Stigma Reduction and Outcomes in Malawi

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Depression - Major Depressive Disorder

HIV

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall aim of this study is to assess the acceptability, feasibility, fidelity, and effectiveness of a depression treatment intervention augmented with counseling to address stigma. Using a multi...

Detailed Description

Stigma and depression are associated with increased HIV-related mortality and morbidity; as depression treatment is increasingly integrated into HIV care, addressing HIV stigma, mental illness stigma,...

Eligibility Criteria

Inclusion

  • Living with HIV and receiving ART at Salima or Mulanje District Hospital
  • Adult (18+ years)
  • Elevated depressive symptoms (PHQ-9 Score ≥5)

Exclusion

  • Pregnant women
  • Severe mental or physical illness

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06951542

Start Date

October 1 2025

End Date

April 1 2027

Last Update

June 4 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Mulanje District Hospital

Mulanje, Malawi

2

Salima District Hospital

Salima, Malawi